June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Jak/STAT signalling mediated glia-neuron interaction following MAPK inhibition
Author Affiliations & Notes
  • Shaoxue Zeng
    Save Sight Institute, The University of Sydney, Sydney, New South Wales, Australia
  • Ting Zhang
    Save Sight Institute, The University of Sydney, Sydney, New South Wales, Australia
  • Yingying Chen
    Save Sight Institute, The University of Sydney, Sydney, New South Wales, Australia
  • Kaiyu Jin
    Pharmaceutical Informatics Institute, College of Pharmaceutical Sciences, Zhejiang University, China
  • Xiaohui Fan
    Pharmaceutical Informatics Institute, College of Pharmaceutical Sciences, Zhejiang University, China
  • Ling Zhu
    Save Sight Institute, The University of Sydney, Sydney, New South Wales, Australia
  • Mark C Gillies
    Save Sight Institute, The University of Sydney, Sydney, New South Wales, Australia
  • Footnotes
    Commercial Relationships   Shaoxue Zeng None; Ting Zhang None; Yingying Chen None; Kaiyu Jin None; Xiaohui Fan None; Ling Zhu None; Mark Gillies None
  • Footnotes
    Support  NONE
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 1176 – A0030. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Shaoxue Zeng, Ting Zhang, Yingying Chen, Kaiyu Jin, Xiaohui Fan, Ling Zhu, Mark C Gillies; Jak/STAT signalling mediated glia-neuron interaction following MAPK inhibition. Invest. Ophthalmol. Vis. Sci. 2022;63(7):1176 – A0030.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The dysfunction of Müller cells can induce photoreceptor degeneration. We have previously identified a link between Müller cells and photoreceptors through which inhibition of MAPK signalling in Müller cells upregulated the expression of Interphotoreceptor Retinoid-Binding Protein (IRBP), which is a photoreceptor-specific protein, and prevented photoreceptor degeneration. However, the exact signalling transduction remains unclear. We aim to explore the signalling between Müller cells and photoreceptors in response to stresses.

Methods : Retinal tissues from four human eye donors were cultured for 24 hours with PD98059, the ERK1/2 inhibitor, or the same concentration of DMSO as controls. Total RNA was extracted, and its quality was assessed. Next-generation sequencing was performed to explore the transcriptional changes after ERK1/2 inhibition. We then performed QIAGEN Ingenuity Pathway Analysis (IPA) on all the differentially expressed genes (P<0.05) to identify canonical pathways that significantly changed after inhibition of MAPK signalling. We also validated the changes of identified signalling pathways after PD98059 treatment in human retinal explants by Western blot. We further treated the human retinal explants with the specific inhibitors of the identified signalling pathway and evaluated the downstream changes compared with the upstream inhibition of MAPK signalling by Western blot.

Results : IPA analysis found JAK/STAT3 signalling pathway, NF-κB Signaling pathway and Interleukin-6 Signaling pathway were significantly inhibited after the inhibition of MAPK in human retinal explants (P<0.05). Western blotting further validated that the treatment of PD98059 significantly inhibited the phosphorylation levels of STAT3 (the ratio of phosphorylated STAT3 to total STAT3). The treatment of 5,15-DPP, STAT3 specific inhibitor, on human retinal explants significantly increased the expression of neuroprotective IRBP protein by photoreceptors.

Conclusions : Our findings suggest that JAK/STAT3 pathway is involved in the signalling between Müller cells and photoreceptors in response to stresses. The inhibition of JAK/STAT3 pathway activity may have neuroprotective effects on the retina.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×